Researchers with the Ludeman Family Center for Women’s Health Research are often looking for participants in their studies. Please check back frequently to see an updated list of studies and qualifications.
Are you a healthy woman between the ages of 18-45?
Do you currently have the birth control implant (Nexplanon®) and have had it for the last 1 to 3 years?
Are you interested in participating in a research study to better understand how genetic differences affect how well contraceptives work?
Study Involvement
Questions? Please contact Delaney Bacon at 303-724-5284 or by email Delaney.bacon@cuanschutz.edu for more information.
Principal Investigator: Aaron Lazorwitz, MD
LINK: https://clinicaltrials.gov/ct2/show/NCT03092037?term=16-2462&draw=2&rank=1
COMIRB #: 16-2462; Version 2.0
Volunteers needed for exercise research studies!
Researchers at the University of Colorado are conducting clinical trials studying the effects of exercise on diabetes.
Are you interested in the benefits that exercise may be able to offer you?
We are looking for:
For more information contact:
The ACTIVE RESEARCH LAB: 303-724-2255 | deirdre.rafferty@ucdenver.edu
Principal Investigator: Jane E.B. Reusch, MD
COMIRB Protocol # 17-0356
LINK: https://clinicaltrials.gov/ct2/show/record/NCT03419195
University of Colorado Denver
LINK TO STUDY PAGE: https://researchstudies.cuanschutz.edu/Search/Study?ProtocolID=4723
Sleep research study at the University of Colorado Boulder, Colorado State University, and Anschutz Medical Campus
Purpose of the Research Study:
This research study is looking at the effect of insufficient sleep on people. Sleeping too little and being awake at the wrong time can impact your ability to think, proteins and hormones in your blood, how your muscle and fat cells work and many other things. This work will be important for people who do not get enough sleep and are at a high risk for developing diabetes and obesity.
Main inclusion/exclusion criteria:
Healthy men and women, ages 18-35
Main procedures involved:
Duration of participation:
7-day laboratory stay
Compensation:
Up to $1,475
Email sleep-study@colostate.edu for study details and ask about the MITO study.
Principal Investigator: Josiane Broussard, PhD
LINK TO STUDY PAGE: https://researchstudies.cuanschutz.edu/Search/Study?ProtocolID=4847
Recently Lost Weight? Want Help Keeping it Off?
Volunteers needed for a research study that will examine the effects of two different diets on weight maintenance.
You may qualify for this study if you:
Participation will include:
Follow this link to complete a pre-screening survey to see if you may qualify: http://j.mp/2qK6ZAw
In order to enroll, all participants must meet specific criteria. The criteria listed above is only a partial list of requirements to participate in this research study. Only a clinical research staff member can determine eligibility.
If you are interested or have any questions, please contact:
CONTACT: Ashlie Viramontes
EMAIL: Ashlie.Viramontes@ucdenver.edu
Principal Investigator: Tanya Halliday, PhD, RD
LINK TO STUDY PAGE: https://researchstudies.cuanschutz.edu/Search/Study?ProtocolID=5810
Eligibility:
OR
Click here for more information or to volunteer: https://researchstudies.cuanschutz.edu/Search/Study?ProtocolID=10133
Protocol Number: 18-0220
LINK: https://clinicaltrials.gov/ct2/show/record/NCT03960827
Principal Investigator: Wendy Kohrt, PhD
Study Population
Transgender women from the Denver metropolitan area and/or who utilize health care at University of Colorado Hospital.
Inclusion Criteria:
Exclusion Criteria:
Contact: Sean Iwamoto, MD; 303-724-3662; sean.iwamoto@cuanschutz.edu
Study Link: https://researchstudies.cuanschutz.edu/Search/Study?ProtocolID=9289
Want to know how your hormones regulate your body fat?
We are looking for:
Benefits for study volunteers include:
If you are interested in participating in the BEAM study:
Please contact the BEAM Study @ 720-848-6399
BEAMstudy@ucdenver.edu
Find out if you qualify now! https://redcap.ucdenver.edu/surveys/
Enter code: PDKY9FYJ4
Are you a young woman between 12-21 years old and you have IRREGULAR PERIODS or you have been told that you have PCOS (polycystic ovarian syndrome)?
If you qualify, you will receive at no cost to you:
Principal Investigator: Dr. Melanie Cree Green
LINK TO STUDY PAGE: https://researchstudies.cuanschutz.edu/Search/Study?ProtocolID=10028
For more information, call (720) 777-6984
Email: yesenia.garciareyes@childrenscolorado.org
COMIRB # 19-0636
This research study is investigating bone health in adults with type 1 diabetes.
You may qualify if you are:
A postmenopausal woman who is at least 45 years old
OR
A male between 50-90 years of age
Main procedures involved:
Compensation provided
Contact: Lubna Qamar , 303-724-9925, LUBNA.QAMAR@CUANSCHUTZ.EDU
Principal investigator: Viral Shah, MD
Inclusion Criteria:
Exclusion Criteria:
Contact: Emily Graves 303-724-3514 EMILY.GRAVES@CUANSCHUTZ.EDU
Are you interested in participating in a study to understand the health effects of the time we spend sitting?
The ACTIVE Research Lab is looking for:
Benefits of participation may include:
For more information, contact:
The ACTIVE Research Lab: (720) 848-6690
Kristina.Chapman@cuanschutz.edu
University of Colorado - Anschutz Medical Campus
Principal Investigator: Mary Whipple, PhD
(COMIRB #19-2758)
https://researchstudies.cuanschutz.edu/Search/Study?ProtocolID=11440
Brief Summary:
This is a Phase I multicenter, open-label, dose-ranging, two-dose PK and PD study of injectable LB at administered as a SQ or IM injection at 40 mg and subsequently at 80 mg SQ or IM depending on the pharmacokinetic and pharmacodynamic results obtained at 40 mg.This study is studying levonorgestrel butanoate (LB) as a possible long-acting and reversible injectable formulation for female contraception.
Criteria
Exclusion Criteria:
Contact: Eva Dindinger 303-724-8482 eva.dindinger@ucdenver.edu
Principal Investigator: Stephanie Teal, MD, MPH; Aaron Lazorwitz, MD, MSCS
Eligibility
PI: Rebecca Cohen, MD, MPH; STEPHANIE TEAL, MD
CONTACT: Noelia Montford
(720) 745-1856
Naila.Naushad@CuAnschutz.edu
Do you or one of your family members have Rheumatoid Arthritis (RA)?
Prevalence of rheumatoid arthritis (RA) is 3x higher in women than in men. The purpose of this study is to learn more about how RA develops in women and why women are differentially affected by this disease.
We are looking for women to take part in this study; participation will include completion of the following activities:
Who qualifies for this study?
Compensation Provided:
In addition to being paid (up to $70 per visit), you will receive
• Free detailed auto-antibody test results
• Free joint exam
Check if you qualify: https://is.gd/FIERAscreen
Contact: Laura Lenis Charry, Research Assistant
Ph: (303)724-0071; Em: LAURA.LENISCHARRY@CUANSCHUTZ.EDU
Location info: Barbara Davis Center (at Anschutz Medical Campus); 1775 Aurora Ct, Aurora, CO 80045
Brief Summary:
This study is being conducted to evaluate the potential therapeutic role of hyperoxia when applied in the immediate ischemic period following a stroke in the controlled Emergency Department setting. The study will evaluate the effects of hyperoxia in stroke patients on the production of markers of free radical damage and inflammatory markers associated with hyperoxic lung injury.
Inclusion Criteria:
Exclusion Criteria:
Contact: Layne Dylla, MD, PhD; 720-848-6777; layne.dylla@cuanschutz.edu
Enrolling by invitation
Are you a woman diagnosed with breast cancer? Do you experience reproductive concerns due to cancer?
Volunteers are needed for a research study exploring the relationship between meaning and psychological distress in young women with breast cancer who experienced reproductive concerns due to cancer diagnosis and treatment and their partners.
You may qualify if you are:
Participation will include:
Completion of two online or in-person questionnaires over a six-month period (Compensation provided).
You will also have the opportunity to refer your partner to participate in the study.
Note: You are not required to have a partner in order to participate.
If you are interested or have questions, please call research staff Alaina Carr and Sydneyjane Roberts at 720-848-8090 or email at oncpsych@ucdenver.edu.
The criteria mentioned above is only a partial list. If you are interested and believe you might be eligible to participate, please go to this link https://redcap.ucdenver.edu/surveys/?s=P79T3CY7FD.
Inclusions
Exclusions:
Contact: Heather Leach, PhD
Questions: Ethan Clark (720) 848-7103; ethan.w.clark@cuanschutz.edu
This is a double-blind, placebo-controlled, crossover study testing whether Vyvanse (lisdexamfetamine; LDX) improves executive functioning (EF) in 100 postmenopausal women who report onset of EF difficulties after oophorectomy. This study involves magnetic resonance imaging (MRI) to see how LDX affects brain chemistry while undergoing two 6-week trials of the study drug and placebo capsules. UPDATE: We have recently updated this protocol (09/2020) to offer a remote version of the study that can be completed entirely from the participant's home. This alternate version of the study eliminates travel, the MRI, and blood draws.
Inclusion Criteria:
Exclusion criteria:
Contact: Brianna Soreth, MA; 215-573-9695; brianna.soreth@pennmedicine.upenn.edu
Principal Investigator: C. Neill Epperson, MD
Eligibility
Contact: Deirdre Rafferty, MS 720-848-6688 deirdre.rafferty@cuanschutz.edu
Contact: Kristina Chapman, BS 720-848-6690 kristina.chapman@cuanschutz.edu
Principal Investigator: Judy Regensteiner, PhD
Principal Investigator: Jane Reusch, MD
University of Virginia
Charlottesville, Virginia, United States, 22908
Contact: Lee Hartline, MEd 434-924-5247 lmh9d@virginia.edu
Contact: Linda Jahn, RN 434-924-1134 las6e@virginia.edu
Principal Investigator: Zhenqi Liu, MD
The purpose of this research study is to determine the impact of high vs. low iron exposure in exclusively formula-fed infants during the first months of life in high resource settings. This is a four month-long study, beginning at birth. The first study visit is conducted at the University of Colorado Hospital and the last visit takes place at Children’s Hospital Colorado. The other four visits are conducted in your home.
Formula is provided to all study participants for the duration of the study!
Compensation is also provided.
Main Procedures Involved:
Duration of Participation: 4 months
Principal Investigator
Minghua Tang, PhD
Contact: Stephanie Gilley, MD, PhD STEPHANIE.GILLEY@CUANSCHUTZ.EDU
Brief Study Description:
The IPAP Project wants to know if taking part in a group-based interpersonal psychotherapy (IPT) program designed to improve mood and lessen stress in girls with PCOS will improve depression, unhealthy eating behaviors, weight, and insulin resistance.
Brief Study Timeline:
Inclusion Criteria
Exclusion Criteria:
To take part in this research study or for more information, please call or text: Maggie Kaiser at 970-286-5577 or email ipapstudy@childrenscolorado.org
Principal Investigator: Lauren Gulley at Colorado State University, University of Colorado Denver, and Children’s Hospital Colorado Co-
Investigator/Mentor:
Melanie Cree-Green, MD, PhD
Melanie.green@childrenscolorado.org;
Co-Investigator/Mentor:
Lauren B. Shomaker, PhD
Lauren.shomaker@childrenscolorado.org;
Co-Investigator:
Eliza Buyers, MD
Eliza.buyers@childrenscolorado.org
This study plans to learn more about how triglyceride levels in pregnancy affect newborn fat mass. Obesity in pregnancy, in the absence of gestational diabetes, is now the most common cause of large-for-gestational-age infants and increased newborn fat mass. Previous data supports the idea that maternal triglycerides, not glucose, are the strongest predictor of both total newborn fat mass and liver fat. In this study, mothers will monitor triglyceride and glucose levels at specific points in pregnancy using point-of-care meters at home. Two weeks after birth, infants will have total fat measured by air-displacement plethysmography (PEAPOD) and liver fat measures by Magnetic Resonance Spectroscopy (MRS). The central hypothesis is that in obesity, fasting triglycerides and postprandial triglycerides will predict newborn fat mass in a free-living environment.
Ages Eligible for Study: up to 39 Years (Child, Adult)
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Yes
Study Population: Overweight and obese pregnant women between the ages of 20-39 years old, who are receiving care at a University of Colorado Health Facility.
Inclusion Criteria:
Exclusion Criteria:
Principal Investigator: Linda A Barbour, MD, MSPH
Principal Investigator: Teri L Hernandez, PhD, RN
Contact: Emily Z Dunn, MS,
303-724-0320
Emily.2.Dunn@cuanschutz.edu
Nicole Hirsch, MS
303-724-0572
Nicole.Hirsch@cuanschutz.edu
This randomized control trial examines differences in glycemia and insulin sensitivity, acute and 1-month glucose fluctuations and 1-month glucose disposal pathways between two physical activity strategies: BREAK and ONE. The BREAK strategy consists of 5-minute bouts of brisk walking performed hourly for 9 hours/day, 5 days per week, and the ONE strategy consists of a single 45-minute bout of brisk walking 5 days per week. The intervention will be maintained for two more months and glucose control will be tested. Participants will be male and female adult volunteers with overweight or obesity and pre-diabetes, a population that may be seeking physical activity options to control glucose.
Age
Adult
Eligibility
Inclusion Criteria:
Exclusion Criteria:
Principal Investigator:
Audrey Bergouignan, PhD
University of Colorado Anschutz Medical Campus
Email: ana.pinto@cuanschutz.edu
Eligibility
Generally healthy premenopausal (ages 18-55 years) and postmenopausal women (ages 45-55) years of all races/ethnicities will be enrolled.
Exclusion criteria:
Principal Investigator: Lyndsey DuBose, PhD
University of Colorado Anschutz Medical Campus
Contact PI: Lyndsey DuBose, PhD tel: 720-848-5596 lyndsey.dubose@cuanschutz.edu
Contact: Kerrie Moreau, PhD tel: 303-724-1914 kerrie.moreau@cuanschutz.edu
We are recruiting individuals who experience PTSD-associated nightmares to participate in a research study to help us understand if improving sleep quality, by reducing the impact of nightmares can improve cardiovascular health. We are recruiting volunteers who experience PTSD-related nightmares to participate in a research study. Main procedures include: Sleep monitoring and nightmare intervention, assessment of bone mineral density and body composition, ultrasound of blood vessels, cognitive and psychological assessments, blood draw
Eligibility
1) Experience repetitive nightmares
2) Men and women age 22 years or older
3) No uncontrolled high blood pressure
4) Non-smoking
5) No history of cancer, diabetes, or cardiovascular/heart disease
6) No use of hormone therapy currently or in the last 6 months
Principal Investigator: Kerrie Moreau, PhD
University of Colorado Anschutz Medical Campus
Contact: kerrie.moreau@cuanschutz.edu
Sign up to receive health news and notices of events, funding opportunities and research studies seeking participants.
CU Anschutz Health and Wellness Center
12348 East Montview Boulevard
Mail Stop C-263
Aurora, CO 80045
303-724-0305